Exploring The Growth Of The Sleep Apnea Oral Appliances Market To $0.9 Billion

By Author: Markets and Markets
Total Articles: 161
Comment this article

The global sleep apnea oral appliances market is projected to reach USD 0.9 Billion by 2028 from USD 0.4 Billion in 2023, at a CAGR of 15.2% during the forecast period.

https://www.marketsandmarkets.com/Market-Reports/sleep-apnea-oral-appliances-market-105423877.html

The growth of this market is majorly driven by the increasing number of customized or personalised oral appliance, and collaboration between dentists and sleep specialists. However, the risks associated with sleep apnea oral appliances for obstructive sleep apnea treatment may restrain the market growth.

Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=105423877

Sleep Apnea Oral Appliances Market by Product (Mandibular Advancement Devices (MAD), Tongue-Retaining Devices (TRD)), Purchase Type (Physician-prescribed), Gender (Male, Female), Age Group, Distribution Channel (Online, Retail) - Global Forecast to 2028

Based on product, the sleep apnea oral appliances market is divided into three main categories—mandibular advancement devices (MADs), tongue-retaining devices (TRDs), and Daytime Nighttime ...
... Appliance (DNA). In 2022, the mandibular advancement devices segment accounted for the largest share of the sleep apnea oral appliances market. The large share of this segment can be attributed to technological advancements have improved the design, comfort, and effectiveness of MADs.

Base on purchase type, the sleep apnea oral appliances market is segmented into – physician-prescribed/ customized oral appliances and online OTC oral appliances. The physician-prescribed/customized oral appliances segment accounted for the largest share of the sleep apnea oral appliances market in 2022. Factors supporting the growth of this segment include rising demand for effective alternatives for managing sleep apnea under the guidance and recommendation of healthcare professionals.

On the basis of gender, the sleep apnea oral appliances market is segmented into male and female. In 2022, the male segment dominated this market. The large share of this segment can be attributed to the anatomical differences in upper airway, throat and neck structure between men and women

On the basis of region, the global sleep apnea oral appliances market is categorized into the North America, Europe, Asia-Pacific, and the RoW segments. North America holds the largest market share in 2022 due to the ongoing research and development initiatives by companies in North America for sleep apnea oral appliances innovation and rising aging population. Other factors boosting the demand for this market include advancement in telemedicine and remote monitoring to make sleep apnea treatment more accessible for patients.

Major Companies:

SomnoMed (Australia), ResMed (US), Whole You, Inc. (US), ProSomnus Sleep Technologies (US), Vivos Therapeutics, Inc. (US), Open Airway Dental Solutions Ltd. (Canada), Panthera Dental (Canada), Airway Management (US), Apnea Sciences (US), DynaFlex (US), OravanOSA (US), Myerson LLC (US), MPowrx Health & Wellness (Canada), The Snore Reliever Company, LLC (US), The Pure Sleep Company (US), Tomed GmbH (Germany), The Aurum Group (Canada), Erkodent Erich Kopp GmbH (Germany), OSCIMED SA (Switzerland), SICAT GmbH & Co. Kg. (Germany), Glidewell (US), ApnoMed (US), ZYPPAH (US), Dream Systems Dental Sleep Laboratory (US), and Alive Med (UAE)

Recent Developments of Sleep Apnea Oral Appliances Industry

In 2023, Vivos Therapeutics, Inc. (US) DNA appliance was granted 510(k) clearance from the U.S. Food & Drug Administration (or FDA) as a Class II medical device in December 2022 for the treatment of snoring and mild to moderate OSA in adults.

In 2022, ResMed (US) acquired the German-based clinical, financial, and operational solutions provider MEDIFOX DAN (Germany) to drive leadership in out-of-hospital software solutions.

In 2021, SomoMed (Australia) conducted SomSUMMIT ’21, which aimed to enhance research, education, and awareness of oral appliance therapy as a primary solution to successful OSA treatment.